Medpace Holdings Inc

20 Aug 2026, 19:41 UTC

Medpace Holdings Inc. is rising amid strong gains in the Life Sciences Tools & Services sector and positive sentiment surrounding biotech investments.

19 Aug 2026, 20:02 UTC

Medpace Holdings Inc. shares are higher, driven by a significant advance in the Life Sciences Tools & Services sub-sector amid a strong market session.

17 Aug 2026, 20:02 UTC

Medpace Holdings Inc. shares are higher following a Barron's report suggesting significant upside potential and robust Q2 results exceeding analyst expectations.

14 Aug 2026, 19:36 UTC

Medpace Holdings Inc shares are lower amid broader market sentiment following a Commerce Department report showing a decline in retail sales for July.

13 Aug 2026, 19:56 UTC

Medpace Holdings shares are lower as CEO August J. Troendle sold 23,144 shares valued at $13.98 million, raising investor concerns about future performance.

7 Aug 2026, 19:16 UTC

Medpace Holdings Inc. shares are lower today, reflecting a slight pullback amid broader market factors, including economic signals and geopolitical tensions.

3 Aug 2026, 19:26 UTC

Medpace Holdings Inc shares are higher, tracking broader market gains as major technology stocks boost investor confidence amid declining energy prices.

30 Jul 2026, 19:22 UTC

Medpace Holdings Inc is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with unusual volatility noted during Thursday's session.

29 Jul 2026, 18:44 UTC

Medpace Holdings Inc. is trading higher, buoyed by the Federal Reserve's steady interest rates, despite broader market pressures from rising oil prices and geopolitical tensions.

28 Jul 2026, 23:11 UTC

Medpace Holdings Inc shares are higher in after-market hours, rebounding after four consecutive lower closes and remaining above the 20-day moving average.

27 Jul 2026, 16:56 UTC

Medpace Holdings Inc. shares are lower amid broader market volatility, despite reporting strong Q2 2026 business awards and raising guidance.

24 Jul 2026, 18:26 UTC

Analyst upgrades from RBC Capital and Truist Securities boost Medpace Holdings' price targets, contributing to modest gains during Friday's trading session.

22 Jul 2026, 23:22 UTC

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

21 Jul 2026, 19:46 UTC

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.